6CM
IMUX icon

683 Capital Management’s Immunic IMUX Stock Holding History

683 Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Sell
147,245
-97,755
-40% -$1.21M 0.11% 96
2026
Q1 		$2.72M Buy
+245,000
New +$2.19M 0.14% 95
2025
Q3 		– Sell
-6,246
Closed -$43.6K – 147
2025
Q2 		$43.6K Sell
6,246
-83,754
-93% -$769K ﹤0.01% 128
2025
Q1 		$981K Buy
90,000
+20,000
+29% +$216K 0.07% 122
2024
Q4 		$700K Buy
70,000
+1,535
+2% +$19.3K 0.04% 129
2024
Q3 		$1.13M Sell
68,465
-1,465
-2% -$20.9K 0.09% 101
2024
Q2 		$776K Hold
69,930
– – 0.06% 105
2024
Q1 		$923K Buy
+69,930
New +$909K 0.07% 91

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

683 Capital Management's IMUX Position: Q2 2026 in Review

683 Capital Management reduced its Immunic (IMUX) stake by 40% in Q2 2026, selling an estimated $1.21M and leaving 147,245 shares worth $2.26M. The position accounts for 0.11% of the portfolio, ranked #96.

683 Capital Management first reported a position in IMUX in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.72M in Q1 2026. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • 683 Capital Management held 147,245 shares of Immunic worth $2.26M as of Q2 2026.
  • 683 Capital Management sold 97,755 Immunic shares in Q2 2026, an estimated $1.21M.
  • Immunic made up 0.11% of 683 Capital Management's portfolio in Q2 2026, its #96 holding.
  • 683 Capital Management first reported a position in Immunic in Q1 2024 and has held it in 8 quarters since.
  • 683 Capital Management's Immunic position peaked at $2.72M in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.